speb/financial-data huggingface dataset:
ORCHASP.NS balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 1218084000.00
ORCHASP.NS cash_flow (annual, 2026-03-31) — Common Stock Issuance: 86000000.00
ORCHASP.NS income_statement (annual, 2026-03-31) — Cost Of Revenue: 221711000.00
ORCHASP.NS income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 47387000.00
ORCHASP.NS balance_sheet (annual, 2026-03-31) — Current Assets: 1636350000.00
ORCHASP.NS balance_sheet (quarterly, 2026-03-31) — Current Assets: 1636350000.00
ORCHASP.NS balance_sheet (annual, 2026-03-31) — Current Liabilities: 1102346000.00
ORCHASP.NS balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 1102346000.00
ORCHASP.NS balance_sheet (annual, 2026-03-31) — Current Provisions: 15208000.00
ORCHASP.NS balance_sheet (quarterly, 2026-03-31) — Current Provisions: 15208000.00
ORCHASP.NS cash_flow (annual, 2026-03-31) — Depreciation: 362000.00
ORCHASP.NS cash_flow (annual, 2026-03-31) — Depreciation And Amortization: 362000.00
ORCHASP.NS income_statement (annual, 2026-03-31) — Depreciation And Amortization In Income Statement: 362000.00
ORCHASP.NS income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 96000.00
ORCHASP.NS income_statement (annual, 2026-03-31) — Depreciation Income Statement: 362000.00
ORCHASP.NS income_statement (quarterly, 2026-03-31) — Depreciation Income Statement: 96000.00
ORCHASP.NS income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 373000000.00
ORCHASP.NS income_statement (quarterly, 2026-03-31) — Diluted EPS: 0.00
ORCHASP.NS income_statement (annual, 2026-03-31) — Diluted NI Availto Com Stockholders: 10520000.00
ORCHASP.NS income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 1119000.00
ORCHASP.NS income_statement (annual, 2026-03-31) — EBIT: 10578000.00
ORCHASP.NS income_statement (quarterly, 2026-03-31) — EBIT: -2224000.00
ORCHASP.NS income_statement (annual, 2026-03-31) — EBITDA: 10940000.00
ORCHASP.NS income_statement (quarterly, 2026-03-31) — EBITDA: -2128000.00
ORCHASP.NS cash_flow (annual, 2026-03-31) — End Cash Position: 3137000.00
ORCHASP.NS cash_flow (annual, 2026-03-31) — Financing Cash Flow: 2727000.00
ORCHASP.NS cash_flow (annual, 2026-03-31) — Free Cash Flow: -42183000.00
ORCHASP.NS balance_sheet (annual, 2026-03-31) — Goodwill And Other Intangible Assets: 141000.00
ORCHASP.NS balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 141000.00
ORCHASP.NS income_statement (annual, 2026-03-31) — Gross Profit: -9149000.00
ORCHASP.NS income_statement (quarterly, 2026-03-31) — Gross Profit: -31261000.00
ORCHASP.NS income_statement (annual, 2026-03-31) — Interest Expense: 0.00
ORCHASP.NS income_statement (quarterly, 2026-03-31) — Interest Expense: 0.00
ORCHASP.NS income_statement (annual, 2026-03-31) — Interest Expense Non Operating: 0.00
ORCHASP.NS income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 0.00
ORCHASP.NS cash_flow (annual, 2026-03-31) — Interest Paid Cff: 0.00
ORCHASP.NS balance_sheet (annual, 2026-03-31) — Invested Capital: 1218084000.00
ORCHASP.NS balance_sheet (quarterly, 2026-03-31) — Invested Capital: 1218084000.00
ORCHASP.NS cash_flow (annual, 2026-03-31) — Investing Cash Flow: 39217000.00
ORCHASP.NS balance_sheet (annual, 2026-03-31) — Investmentin Financial Assets: 682500000.00
ORCHASP.NS balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 682500000.00
ORCHASP.NS cash_flow (annual, 2026-03-31) — Issuance Of Capital Stock: 86000000.00
ORCHASP.NS cash_flow (annual, 2026-03-31) — Net Common Stock Issuance: 86000000.00
ORCHASP.NS income_statement (annual, 2026-03-31) — Net Income: 10520000.00
ORCHASP.NS income_statement (quarterly, 2026-03-31) — Net Income: 1119000.00
ORCHASP.NS income_statement (annual, 2026-03-31) — Net Income Common Stockholders: 10520000.00
ORCHASP.NS income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 1119000.00
ORCHASP.NS income_statement (annual, 2026-03-31) — Net Income Continuous Operations: 10520000.00
ORCHASP.NS income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 1119000.00
ORCHASP.NS income_statement (annual, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 10520000.00
ORCHASP.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 1119000.00
ORCHASP.NS income_statement (annual, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 10520000.00
ORCHASP.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 1119000.00
ORCHASP.NS cash_flow (annual, 2026-03-31) — Net Income From Continuing Operations: 10578000.00
ORCHASP.NS income_statement (annual, 2026-03-31) — Net Income Including Noncontrolling Interests: 10520000.00
ORCHASP.NS income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 1119000.00
ORCHASP.NS income_statement (annual, 2026-03-31) — Net Interest Income: 0.00
ORCHASP.NS income_statement (quarterly, 2026-03-31) — Net Interest Income: 0.00
ORCHASP.NS cash_flow (annual, 2026-03-31) — Net Issuance Payments Of Debt: -83273000.00
ORCHASP.NS income_statement (annual, 2026-03-31) — Net Non Operating Interest Income Expense: 0.00
ORCHASP.NS income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: 0.00
ORCHASP.NS cash_flow (annual, 2026-03-31) — Net Other Investing Changes: 39385000.00
ORCHASP.NS balance_sheet (annual, 2026-03-31) — Net PPE: 935000.00
ORCHASP.NS balance_sheet (quarterly, 2026-03-31) — Net PPE: 935000.00
ORCHASP.NS cash_flow (annual, 2026-03-31) — Net PPE Purchase And Sale: -168000.00
ORCHASP.NS cash_flow (annual, 2026-03-31) — Net Short Term Debt Issuance: -83273000.00
ORCHASP.NS balance_sheet (annual, 2026-03-31) — Net Tangible Assets: 1217943000.00
ORCHASP.NS balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 1217943000.00
ORCHASP.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Assets: 504000.00
ORCHASP.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 504000.00
ORCHASP.NS income_statement (annual, 2026-03-31) — Normalized EBITDA: 10940000.00
ORCHASP.NS income_statement (quarterly, 2026-03-31) — Normalized EBITDA: -2128000.00
ORCHASP.NS income_statement (annual, 2026-03-31) — Normalized Income: 10520000.00
ORCHASP.NS income_statement (quarterly, 2026-03-31) — Normalized Income: 1119000.00
ORCHASP.NS cash_flow (annual, 2026-03-31) — Operating Cash Flow: -42015000.00
ORCHASP.NS income_statement (annual, 2026-03-31) — Operating Income: -28805000.00
ORCHASP.NS income_statement (quarterly, 2026-03-31) — Operating Income: -40854000.00
ORCHASP.NS income_statement (annual, 2026-03-31) — Operating Revenue: 212562000.00
ORCHASP.NS income_statement (quarterly, 2026-03-31) — Operating Revenue: 16126000.00
ORCHASP.NS balance_sheet (annual, 2026-03-31) — Ordinary Shares Number: 346425366.00
ORCHASP.NS balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 346425366.00
ORCHASP.NS balance_sheet (annual, 2026-03-31) — Other Current Assets: 30065000.00
ORCHASP.NS balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 30065000.00
ORCHASP.NS balance_sheet (annual, 2026-03-31) — Other Current Liabilities: 106410000.00
ORCHASP.NS balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 106410000.00
ORCHASP.NS balance_sheet (annual, 2026-03-31) — Other Equity Interest: 525233000.00
ORCHASP.NS balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: 525233000.00
ORCHASP.NS cash_flow (annual, 2026-03-31) — Other Non Cash Items: -39385000.00
ORCHASP.NS income_statement (annual, 2026-03-31) — Other Non Operating Income Expenses: 39385000.00
ORCHASP.NS income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 38632000.00
ORCHASP.NS income_statement (annual, 2026-03-31) — Other Operating Expenses: 19294000.00
ORCHASP.NS income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 9497000.00
ORCHASP.NS balance_sheet (annual, 2026-03-31) — Other Short Term Investments: 590000.00
ORCHASP.NS balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 590000.00
ORCHASP.NS income_statement (annual, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
ORCHASP.NS income_statement (quarterly, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
ORCHASP.NS balance_sheet (annual, 2026-03-31) — Payables: 907442000.00
ORCHASP.NS balance_sheet (quarterly, 2026-03-31) — Payables: 907442000.00
ORCHASP.NS income_statement (annual, 2026-03-31) — Pretax Income: 10578000.00
ORCHASP.NS income_statement (quarterly, 2026-03-31) — Pretax Income: -2224000.00
ORCHASP.NS cash_flow (annual, 2026-03-31) — Purchase Of PPE: -168000.00
ORCHASP.NS income_statement (annual, 2026-03-31) — Reconciled Cost Of Revenue: 221711000.00
ORCHASP.NS income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 47387000.00
ORCHASP.NS income_statement (annual, 2026-03-31) — Reconciled Depreciation: 362000.00
ORCHASP.NS income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 96000.00
ORCHASP.NS cash_flow (annual, 2026-03-31) — Repayment Of Debt: -83273000.00
ORCHASP.NS balance_sheet (annual, 2026-03-31) — Share Issued: 346425366.00
ORCHASP.NS balance_sheet (quarterly, 2026-03-31) — Share Issued: 346425366.00
ORCHASP.NS cash_flow (annual, 2026-03-31) — Short Term Debt Payments: -83273000.00
ORCHASP.NS balance_sheet (annual, 2026-03-31) — Stockholders Equity: 1218084000.00
ORCHASP.NS balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 1218084000.00
ORCHASP.NS balance_sheet (annual, 2026-03-31) — Tangible Book Value: 1217943000.00
ORCHASP.NS balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 1217943000.00
ORCHASP.NS income_statement (annual, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
ORCHASP.NS income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
ORCHASP.NS income_statement (annual, 2026-03-31) — Tax Provision: 58000.00
ORCHASP.NS income_statement (quarterly, 2026-03-31) — Tax Provision: -3343000.00
ORCHASP.NS income_statement (annual, 2026-03-31) — Tax Rate For Calcs: 0.01
ORCHASP.NS income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.40
ORCHASP.NS cash_flow (annual, 2026-03-31) — Taxes Refund Paid: 0.00
ORCHASP.NS balance_sheet (annual, 2026-03-31) — Total Assets: 2320430000.00
ORCHASP.NS balance_sheet (quarterly, 2026-03-31) — Total Assets: 2320430000.00
ORCHASP.NS balance_sheet (annual, 2026-03-31) — Total Capitalization: 1218084000.00
ORCHASP.NS balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 1218084000.00
ORCHASP.NS balance_sheet (annual, 2026-03-31) — Total Equity Gross Minority Interest: 1218084000.00
ORCHASP.NS balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 1218084000.00
ORCHASP.NS income_statement (annual, 2026-03-31) — Total Expenses: 241367000.00
ORCHASP.NS income_statement (quarterly, 2026-03-31) — Total Expenses: 56980000.00
ORCHASP.NS balance_sheet (annual, 2026-03-31) — Total Liabilities Net Minority Interest: 1102346000.00
ORCHASP.NS balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 1102346000.00
ORCHASP.NS balance_sheet (annual, 2026-03-31) — Total Non Current Assets: 684080000.00
ORCHASP.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 684080000.00
ORCHASP.NS balance_sheet (annual, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 0.00
ORCHASP.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 0.00
ORCHASP.NS balance_sheet (annual, 2026-03-31) — Total Tax Payable: 25490000.00
ORCHASP.NS balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 25490000.00
ORCHASP.NS balance_sheet (annual, 2026-03-31) — Working Capital: 534004000.00
ORCHASP.NS balance_sheet (quarterly, 2026-03-31) — Working Capital: 534004000.00
ORCHPHARMA.NS balance_sheet (annual, 2022-03-31) — Accumulated Depreciation: -5823514000.00
ORCHPHARMA.NS balance_sheet (annual, 2022-03-31) — Additional Paid In Capital: 4644786000.00
ORCHPHARMA.NS balance_sheet (annual, 2022-03-31) — Allowance For Doubtful Accounts Receivable: -425559000.00
ORCHPHARMA.NS income_statement (annual, 2022-03-31) — Amortization: 313000.00
ORCHPHARMA.NS cash_flow (annual, 2022-03-31) — Amortization Cash Flow: 313000.00
ORCHPHARMA.NS balance_sheet (annual, 2022-03-31) — Assets Held For Sale Current: 132897000.00
ORCHPHARMA.NS income_statement (annual, 2022-03-31) — Basic Average Shares: 40816400.00
ORCHPHARMA.NS income_statement (annual, 2022-03-31) — Basic EPS: -0.48
ORCHPHARMA.NS balance_sheet (annual, 2022-03-31) — Buildings And Improvements: 1439377000.00
ORCHPHARMA.NS balance_sheet (annual, 2022-03-31) — Cash Equivalents: 0.00
ORCHPHARMA.NS balance_sheet (annual, 2022-03-31) — Cash Financial: 43066000.00
ORCHPHARMA.NS cash_flow (annual, 2022-03-31) — Common Stock Issuance: 0.00
ORCHPHARMA.NS income_statement (annual, 2022-03-31) — Diluted Average Shares: 40816400.00
ORCHPHARMA.NS income_statement (annual, 2022-03-31) — Diluted EPS: -0.48
ORCHPHARMA.NS balance_sheet (annual, 2022-03-31) — Finished Goods: 548449000.00
ORCHPHARMA.NS cash_flow (annual, 2022-03-31) — Gain Loss On Investment Securities: -891810000.00
ORCHPHARMA.NS income_statement (annual, 2022-03-31) — General And Administrative Expense: 86414000.00
ORCHPHARMA.NS balance_sheet (annual, 2022-03-31) — Gross Accounts Receivable: 2131241000.00
ORCHPHARMA.NS income_statement (annual, 2022-03-31) — Interest Income: 4188000.00
ORCHPHARMA.NS income_statement (annual, 2022-03-31) — Interest Income Non Operating: 4188000.00
ORCHPHARMA.NS cash_flow (annual, 2022-03-31) — Issuance Of Capital Stock: 0.00
ORCHPHARMA.NS cash_flow (annual, 2022-03-31) — Issuance Of Debt: 199988000.00
ORCHPHARMA.NS balance_sheet (annual, 2022-03-31) — Land And Improvements: 122873000.00
ORCHPHARMA.NS cash_flow (annual, 2022-03-31) — Long Term Debt Issuance: 199988000.00
ORCHPHARMA.NS cash_flow (annual, 2022-03-31) — Long Term Debt Payments: -2047852000.00
ORCHPHARMA.NS balance_sheet (annual, 2022-03-31) — Machinery Furniture Equipment: 9931734000.00
ORCHPHARMA.NS cash_flow (annual, 2022-03-31) — Net Common Stock Issuance: 0.00
ORCHPHARMA.NS income_statement (annual, 2022-03-31) — Net Income Discontinuous Operations: 584702000.00
ORCHPHARMA.NS balance_sheet (annual, 2022-03-31) — Non Current Deferred Taxes Liabilities: 32262000.00
ORCHPHARMA.NS balance_sheet (annual, 2022-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 110129000.00
ORCHPHARMA.NS balance_sheet (annual, 2022-03-31) — Non Current Prepaid Assets: 100221000.00
ORCHPHARMA.NS balance_sheet (annual, 2022-03-31) — Other Inventories: 23642000.00
ORCHPHARMA.NS income_statement (annual, 2022-03-31) — Other Operating Expenses: 747415000.00
ORCHPHARMA.NS balance_sheet (annual, 2022-03-31) — Other Payable: 5264000.00
ORCHPHARMA.NS balance_sheet (annual, 2022-03-31) — Other Receivables: 14000.00
ORCHPHARMA.NS income_statement (annual, 2022-03-31) — Other Special Charges: -4000.00
ORCHPHARMA.NS balance_sheet (annual, 2022-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 30071000.00
ORCHPHARMA.NS balance_sheet (annual, 2022-03-31) — Prepaid Assets: 268663000.00
ORCHPHARMA.NS balance_sheet (annual, 2022-03-31) — Properties: 0.00
ORCHPHARMA.NS balance_sheet (annual, 2022-03-31) — Raw Materials: 463709000.00
ORCHPHARMA.NS income_statement (annual, 2022-03-31) — Rent And Landing Fees: 15809000.00
ORCHPHARMA.NS income_statement (annual, 2022-03-31) — Rent Expense Supplemental: 15809000.00
ORCHPHARMA.NS cash_flow (annual, 2022-03-31) — Repayment Of Debt: -2047852000.00
ORCHPHARMA.NS income_statement (annual, 2022-03-31) — Research And Development: 66263000.00
ORCHPHARMA.NS balance_sheet (annual, 2022-03-31) — Restricted Cash: 32360000.00
ORCHPHARMA.NS balance_sheet (annual, 2022-03-31) — Retained Earnings: -23143260000.00
ORCHPHARMA.NS cash_flow (annual, 2022-03-31) — Sale Of Business: 1594081000.00
ORCHPHARMA.NS cash_flow (annual, 2022-03-31) — Sale Of Investment: 128446000.00
ORCHPHARMA.NS income_statement (annual, 2022-03-31) — Selling And Marketing Expense: 222617000.00
ORCHPHARMA.NS income_statement (annual, 2022-03-31) — Selling General And Administration: 309031000.00
ORCHPHARMA.NS cash_flow (annual, 2022-03-31) — Short Term Debt Issuance: 199988000.00
ORCHPHARMA.NS income_statement (annual, 2022-03-31) — Total Other Finance Cost: 14443000.00
ORCHPHARMA.NS balance_sheet (annual, 2022-03-31) — Work In Process: 690763000.00
ORCHPHARMA.NS income_statement (annual, 2023-03-31) — +Operating Expense: 2390534000.00
ORCHPHARMA.NS income_statement (annual, 2023-03-31) — +Total Revenue: 6658984000.00
ORCHPHARMA.NS balance_sheet (annual, 2023-03-31) — Accounts Payable: 1743681000.00
ORCHPHARMA.NS balance_sheet (annual, 2023-03-31) — Accounts Receivable: 2151938000.00
ORCHPHARMA.NS balance_sheet (annual, 2023-03-31) — Accumulated Depreciation: -6370921000.00
ORCHPHARMA.NS balance_sheet (annual, 2023-03-31) — Additional Paid In Capital: 4644786000.00
ORCHPHARMA.NS balance_sheet (annual, 2023-03-31) — Allowance For Doubtful Accounts Receivable: -437442000.00
ORCHPHARMA.NS income_statement (annual, 2023-03-31) — Amortization: 78000.00
ORCHPHARMA.NS cash_flow (annual, 2023-03-31) — Amortization Cash Flow: 78000.00
ORCHPHARMA.NS balance_sheet (annual, 2023-03-31) — Assets Held For Sale Current: 0.00
ORCHPHARMA.NS balance_sheet (annual, 2023-03-31) — Available For Sale Securities: 444413000.00
ORCHPHARMA.NS income_statement (annual, 2023-03-31) — Basic Average Shares: 40816400.00
ORCHPHARMA.NS income_statement (annual, 2023-03-31) — Basic EPS: 11.35
ORCHPHARMA.NS cash_flow (annual, 2023-03-31) — Beginning Cash Position: 43066000.00
ORCHPHARMA.NS balance_sheet (annual, 2023-03-31) — Buildings And Improvements: 1782577000.00
ORCHPHARMA.NS cash_flow (annual, 2023-03-31) — Capital Expenditure: -849131000.00
ORCHPHARMA.NS balance_sheet (annual, 2023-03-31) — Capital Lease Obligations: 0.00
ORCHPHARMA.NS balance_sheet (annual, 2023-03-31) — Capital Stock: 408164000.00
ORCHPHARMA.NS balance_sheet (annual, 2023-03-31) — Cash And Cash Equivalents: 225971000.00
ORCHPHARMA.NS balance_sheet (annual, 2023-03-31) — Cash Cash Equivalents And Short Term Investments: 275207000.00
ORCHPHARMA.NS balance_sheet (annual, 2023-03-31) — Cash Equivalents: 0.00
ORCHPHARMA.NS balance_sheet (annual, 2023-03-31) — Cash Financial: 225971000.00
ORCHPHARMA.NS cash_flow (annual, 2023-03-31) — Change In Inventory: -560817000.00
ORCHPHARMA.NS cash_flow (annual, 2023-03-31) — Change In Other Current Assets: 105684000.00
ORCHPHARMA.NS cash_flow (annual, 2023-03-31) — Change In Payable: 139141000.00
ORCHPHARMA.NS cash_flow (annual, 2023-03-31) — Change In Receivables: -416535000.00
ORCHPHARMA.NS cash_flow (annual, 2023-03-31) — Change In Working Capital: -790621000.00
ORCHPHARMA.NS cash_flow (annual, 2023-03-31) — Changes In Cash: 182905000.00
ORCHPHARMA.NS balance_sheet (annual, 2023-03-31) — Common Stock: 408164000.00
ORCHPHARMA.NS balance_sheet (annual, 2023-03-31) — Common Stock Equity: 6886490000.00
ORCHPHARMA.NS cash_flow (annual, 2023-03-31) — Common Stock Issuance: 0.00
ORCHPHARMA.NS balance_sheet (annual, 2023-03-31) — Construction In Progress: 484845000.00
ORCHPHARMA.NS income_statement (annual, 2023-03-31) — Cost Of Revenue: 3971760000.00
ORCHPHARMA.NS balance_sheet (annual, 2023-03-31) — Current Assets: 5010097000.00
ORCHPHARMA.NS balance_sheet (annual, 2023-03-31) — Current Capital Lease Obligation: 0.00
ORCHPHARMA.NS balance_sheet (annual, 2023-03-31) — Current Debt: 1825081000.00
ORCHPHARMA.NS balance_sheet (annual, 2023-03-31) — Current Debt And Capital Lease Obligation: 1825081000.00
ORCHPHARMA.NS balance_sheet (annual, 2023-03-31) — Current Liabilities: 3718917000.00
ORCHPHARMA.NS balance_sheet (annual, 2023-03-31) — Current Provisions: 34860000.00
ORCHPHARMA.NS cash_flow (annual, 2023-03-31) — Depreciation: 547790000.00
ORCHPHARMA.NS cash_flow (annual, 2023-03-31) — Depreciation And Amortization: 547868000.00
ORCHPHARMA.NS income_statement (annual, 2023-03-31) — Depreciation And Amortization In Income Statement: 547868000.00
ORCHPHARMA.NS income_statement (annual, 2023-03-31) — Depreciation Income Statement: 547790000.00
ORCHPHARMA.NS income_statement (annual, 2023-03-31) — Diluted Average Shares: 40816400.00
ORCHPHARMA.NS income_statement (annual, 2023-03-31) — Diluted EPS: 11.35
ORCHPHARMA.NS income_statement (annual, 2023-03-31) — Diluted NI Availto Com Stockholders: 463183000.00
ORCHPHARMA.NS income_statement (annual, 2023-03-31) — EBIT: 874726000.00
ORCHPHARMA.NS income_statement (annual, 2023-03-31) — EBITDA: 1422594000.00
ORCHPHARMA.NS cash_flow (annual, 2023-03-31) — End Cash Position: 225971000.00
ORCHPHARMA.NS cash_flow (annual, 2023-03-31) — Financing Cash Flow: 311664000.00
ORCHPHARMA.NS balance_sheet (annual, 2023-03-31) — Finished Goods: 679466000.00
ORCHPHARMA.NS cash_flow (annual, 2023-03-31) — Free Cash Flow: -665751000.00
ORCHPHARMA.NS cash_flow (annual, 2023-03-31) — Gain Loss On Investment Securities: -154000.00
ORCHPHARMA.NS cash_flow (annual, 2023-03-31) — Gain Loss On Sale Of PPE: -399850000.00
ORCHPHARMA.NS income_statement (annual, 2023-03-31) — General And Administrative Expense: 87865000.00
ORCHPHARMA.NS balance_sheet (annual, 2023-03-31) — Goodwill And Other Intangible Assets: 3857000.00
ORCHPHARMA.NS balance_sheet (annual, 2023-03-31) — Gross Accounts Receivable: 2589380000.00
ORCHPHARMA.NS balance_sheet (annual, 2023-03-31) — Gross PPE: 12582854000.00
ORCHPHARMA.NS income_statement (annual, 2023-03-31) — Gross Profit: 2687224000.00
ORCHPHARMA.NS income_statement (annual, 2023-03-31) — Interest Expense: 322257000.00
ORCHPHARMA.NS income_statement (annual, 2023-03-31) — Interest Expense Non Operating: 322257000.00
ORCHPHARMA.NS income_statement (annual, 2023-03-31) — Interest Income: 6180000.00
ORCHPHARMA.NS income_statement (annual, 2023-03-31) — Interest Income Non Operating: 6180000.00
ORCHPHARMA.NS cash_flow (annual, 2023-03-31) — Interest Paid Cff: -322257000.00
ORCHPHARMA.NS cash_flow (annual, 2023-03-31) — Interest Received Cfi: 4610000.00
ORCHPHARMA.NS balance_sheet (annual, 2023-03-31) — Inventory: 2287380000.00
ORCHPHARMA.NS balance_sheet (annual, 2023-03-31) — Invested Capital: 10199947000.00
ORCHPHARMA.NS cash_flow (annual, 2023-03-31) — Investing Cash Flow: -312139000.00
ORCHPHARMA.NS balance_sheet (annual, 2023-03-31) — Investmentin Financial Assets: 444413000.00
ORCHPHARMA.NS cash_flow (annual, 2023-03-31) — Issuance Of Capital Stock: 0.00
ORCHPHARMA.NS cash_flow (annual, 2023-03-31) — Issuance Of Debt: 1731984000.00
ORCHPHARMA.NS balance_sheet (annual, 2023-03-31) — Land And Improvements: 218474000.00
ORCHPHARMA.NS balance_sheet (annual, 2023-03-31) — Long Term Capital Lease Obligation: 0.00
ORCHPHARMA.NS balance_sheet (annual, 2023-03-31) — Long Term Debt: 1488376000.00
ORCHPHARMA.NS balance_sheet (annual, 2023-03-31) — Long Term Debt And Capital Lease Obligation: 1488376000.00
ORCHPHARMA.NS cash_flow (annual, 2023-03-31) — Long Term Debt Issuance: 1731984000.00
ORCHPHARMA.NS cash_flow (annual, 2023-03-31) — Long Term Debt Payments: -1098063000.00
ORCHPHARMA.NS balance_sheet (annual, 2023-03-31) — Long Term Provisions: 126018000.00
ORCHPHARMA.NS balance_sheet (annual, 2023-03-31) — Machinery Furniture Equipment: 9933773000.00
ORCHPHARMA.NS cash_flow (annual, 2023-03-31) — Net Business Purchase And Sale: 0.00
ORCHPHARMA.NS cash_flow (annual, 2023-03-31) — Net Common Stock Issuance: 0.00
ORCHPHARMA.NS balance_sheet (annual, 2023-03-31) — Net Debt: 3087486000.00
ORCHPHARMA.NS cash_flow (annual, 2023-03-31) — Net Foreign Currency Exchange Gain Loss: 16444000.00
ORCHPHARMA.NS income_statement (annual, 2023-03-31) — Net Income: 463183000.00
ORCHPHARMA.NS income_statement (annual, 2023-03-31) — Net Income Common Stockholders: 463183000.00
ORCHPHARMA.NS income_statement (annual, 2023-03-31) — Net Income Continuous Operations: 530934000.00
ORCHPHARMA.NS income_statement (annual, 2023-03-31) — Net Income Discontinuous Operations: -67751000.00
ORCHPHARMA.NS income_statement (annual, 2023-03-31) — Net Income From Continuing And Discontinued Operation: 463183000.00
ORCHPHARMA.NS income_statement (annual, 2023-03-31) — Net Income From Continuing Operation Net Minority Interest: 530934000.00
ORCHPHARMA.NS cash_flow (annual, 2023-03-31) — Net Income From Continuing Operations: 463183000.00
ORCHPHARMA.NS income_statement (annual, 2023-03-31) — Net Income Including Noncontrolling Interests: 463183000.00
ORCHPHARMA.NS income_statement (annual, 2023-03-31) — Net Interest Income: -322842000.00
ORCHPHARMA.NS cash_flow (annual, 2023-03-31) — Net Investment Purchase And Sale: -53073000.00
ORCHPHARMA.NS cash_flow (annual, 2023-03-31) — Net Issuance Payments Of Debt: 633921000.00
ORCHPHARMA.NS cash_flow (annual, 2023-03-31) — Net Long Term Debt Issuance: 633921000.00
ORCHPHARMA.NS income_statement (annual, 2023-03-31) — Net Non Operating Interest Income Expense: -322842000.00
ORCHPHARMA.NS balance_sheet (annual, 2023-03-31) — Net PPE: 6211933000.00
ORCHPHARMA.NS cash_flow (annual, 2023-03-31) — Net PPE Purchase And Sale: -263676000.00
ORCHPHARMA.NS cash_flow (annual, 2023-03-31) — Net Short Term Debt Issuance: 1731984000.00
ORCHPHARMA.NS balance_sheet (annual, 2023-03-31) — Net Tangible Assets: 6882633000.00
ORCHPHARMA.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Liabilities: 32262000.00
ORCHPHARMA.NS balance_sheet (annual, 2023-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 126018000.00
ORCHPHARMA.NS balance_sheet (annual, 2023-03-31) — Non Current Prepaid Assets: 68748000.00
ORCHPHARMA.NS income_statement (annual, 2023-03-31) — Normalized EBITDA: 1022590000.00
ORCHPHARMA.NS income_statement (annual, 2023-03-31) — Normalized Income: 130930000.00
ORCHPHARMA.NS cash_flow (annual, 2023-03-31) — Operating Cash Flow: 183380000.00
ORCHPHARMA.NS income_statement (annual, 2023-03-31) — Operating Income: 296690000.00
ORCHPHARMA.NS income_statement (annual, 2023-03-31) — Operating Revenue: 6658984000.00
ORCHPHARMA.NS balance_sheet (annual, 2023-03-31) — Ordinary Shares Number: 40816400.00
ORCHPHARMA.NS balance_sheet (annual, 2023-03-31) — Other Current Assets: 253396000.00
ORCHPHARMA.NS balance_sheet (annual, 2023-03-31) — Other Current Liabilities: 14836000.00
ORCHPHARMA.NS balance_sheet (annual, 2023-03-31) — Other Equity Interest: 685606000.00
ORCHPHARMA.NS balance_sheet (annual, 2023-03-31) — Other Intangible Assets: 3857000.00
ORCHPHARMA.NS balance_sheet (annual, 2023-03-31) — Other Inventories: 39907000.00
ORCHPHARMA.NS cash_flow (annual, 2023-03-31) — Other Non Cash Items: 316077000.00
ORCHPHARMA.NS balance_sheet (annual, 2023-03-31) — Other Non Current Assets: 20214000.00
ORCHPHARMA.NS income_statement (annual, 2023-03-31) — Other Non Operating Income Expenses: 126602000.00
ORCHPHARMA.NS income_statement (annual, 2023-03-31) — Other Operating Expenses: 859732000.00
ORCHPHARMA.NS balance_sheet (annual, 2023-03-31) — Other Payable: 83700000.00
ORCHPHARMA.NS balance_sheet (annual, 2023-03-31) — Other Properties: 163185000.00
ORCHPHARMA.NS balance_sheet (annual, 2023-03-31) — Other Receivables: 1584000.00
ORCHPHARMA.NS balance_sheet (annual, 2023-03-31) — Other Short Term Investments: 49236000.00
ORCHPHARMA.NS income_statement (annual, 2023-03-31) — Other Special Charges: -399850000.00
ORCHPHARMA.NS income_statement (annual, 2023-03-31) — Otherunder Preferred Stock Dividend: 0.00
ORCHPHARMA.NS balance_sheet (annual, 2023-03-31) — Payables: 1827381000.00
ORCHPHARMA.NS balance_sheet (annual, 2023-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 34860000.00
ORCHPHARMA.NS balance_sheet (annual, 2023-03-31) — Prepaid Assets: 253396000.00
ORCHPHARMA.NS income_statement (annual, 2023-03-31) — Pretax Income: 552469000.00
ORCHPHARMA.NS balance_sheet (annual, 2023-03-31) — Properties: 0.00
ORCHPHARMA.NS cash_flow (annual, 2023-03-31) — Provisionand Write Offof Assets: 11883000.00
ORCHPHARMA.NS cash_flow (annual, 2023-03-31) — Purchase Of Business: 0.00
ORCHPHARMA.NS cash_flow (annual, 2023-03-31) — Purchase Of Investment: -53073000.00
ORCHPHARMA.NS cash_flow (annual, 2023-03-31) — Purchase Of PPE: -849131000.00
ORCHPHARMA.NS balance_sheet (annual, 2023-03-31) — Raw Materials: 793507000.00
ORCHPHARMA.NS income_statement (annual, 2023-03-31) — Reconciled Cost Of Revenue: 3971760000.00
ORCHPHARMA.NS income_statement (annual, 2023-03-31) — Reconciled Depreciation: 547868000.00
ORCHPHARMA.NS income_statement (annual, 2023-03-31) — Rent And Landing Fees: 10160000.00
ORCHPHARMA.NS income_statement (annual, 2023-03-31) — Rent Expense Supplemental: 10160000.00
ORCHPHARMA.NS cash_flow (annual, 2023-03-31) — Repayment Of Debt: -1098063000.00
ORCHPHARMA.NS income_statement (annual, 2023-03-31) — Research And Development: 63621000.00
ORCHPHARMA.NS balance_sheet (annual, 2023-03-31) — Restricted Cash: 31055000.00
ORCHPHARMA.NS balance_sheet (annual, 2023-03-31) — Retained Earnings: -22682405000.00
ORCHPHARMA.NS cash_flow (annual, 2023-03-31) — Sale Of Business: 576100000.00
ORCHPHARMA.NS cash_flow (annual, 2023-03-31) — Sale Of PPE: 585455000.00
ORCHPHARMA.NS income_statement (annual, 2023-03-31) — Selling And Marketing Expense: 143363000.00
ORCHPHARMA.NS income_statement (annual, 2023-03-31) — Selling General And Administration: 231228000.00
ORCHPHARMA.NS balance_sheet (annual, 2023-03-31) — Share Issued: 40816400.00
ORCHPHARMA.NS cash_flow (annual, 2023-03-31) — Short Term Debt Issuance: 1731984000.00
ORCHPHARMA.NS income_statement (annual, 2023-03-31) — Special Income Charges: 399850000.00
ORCHPHARMA.NS balance_sheet (annual, 2023-03-31) — Stockholders Equity: 6886490000.00
ORCHPHARMA.NS balance_sheet (annual, 2023-03-31) — Tangible Book Value: 6882633000.00
ORCHPHARMA.NS income_statement (annual, 2023-03-31) — Tax Effect Of Unusual Items: 0.00
ORCHPHARMA.NS income_statement (annual, 2023-03-31) — Tax Provision: 0.00
ORCHPHARMA.NS income_statement (annual, 2023-03-31) — Tax Rate For Calcs: 0.00
ORCHPHARMA.NS balance_sheet (annual, 2023-03-31) — Taxes Receivable: 9537000.00
ORCHPHARMA.NS cash_flow (annual, 2023-03-31) — Taxes Refund Paid: -2985000.00
ORCHPHARMA.NS balance_sheet (annual, 2023-03-31) — Total Assets: 12252063000.00
ORCHPHARMA.NS balance_sheet (annual, 2023-03-31) — Total Capitalization: 8374866000.00
ORCHPHARMA.NS balance_sheet (annual, 2023-03-31) — Total Debt: 3313457000.00
ORCHPHARMA.NS balance_sheet (annual, 2023-03-31) — Total Equity Gross Minority Interest: 6886490000.00
ORCHPHARMA.NS income_statement (annual, 2023-03-31) — Total Expenses: 6362294000.00
ORCHPHARMA.NS balance_sheet (annual, 2023-03-31) — Total Liabilities Net Minority Interest: 5365573000.00
ORCHPHARMA.NS balance_sheet (annual, 2023-03-31) — Total Non Current Assets: 7241966000.00
ORCHPHARMA.NS balance_sheet (annual, 2023-03-31) — Total Non Current Liabilities Net Minority Interest: 1646656000.00
ORCHPHARMA.NS income_statement (annual, 2023-03-31) — Total Other Finance Cost: 6765000.00
ORCHPHARMA.NS income_statement (annual, 2023-03-31) — Total Unusual Items: 400004000.00
ORCHPHARMA.NS income_statement (annual, 2023-03-31) — Total Unusual Items Excluding Goodwill: 400004000.00
ORCHPHARMA.NS balance_sheet (annual, 2023-03-31) — Work In Process: 774500000.00
ORCHPHARMA.NS balance_sheet (annual, 2023-03-31) — Working Capital: 1291180000.00
ORCHPHARMA.NS income_statement (annual, 2023-03-31) — Write Off: 0.00
ORCHPHARMA.NS income_statement (annual, 2024-03-31) — +Operating Expense: 2422106000.00
ORCHPHARMA.NS income_statement (annual, 2024-03-31) — +Total Revenue: 8190663000.00
ORCHPHARMA.NS balance_sheet (annual, 2024-03-31) — Accounts Payable: 2295769000.00
ORCHPHARMA.NS balance_sheet (annual, 2024-03-31) — Accounts Receivable: 1955471000.00
ORCHPHARMA.NS balance_sheet (annual, 2024-03-31) — Accumulated Depreciation: -6692017000.00
ORCHPHARMA.NS balance_sheet (annual, 2024-03-31) — Additional Paid In Capital: 8465180000.00
ORCHPHARMA.NS balance_sheet (annual, 2024-03-31) — Allowance For Doubtful Accounts Receivable: -434791000.00
ORCHPHARMA.NS income_statement (annual, 2024-03-31) — Amortization: 11306000.00
ORCHPHARMA.NS cash_flow (annual, 2024-03-31) — Amortization Cash Flow: 11306000.00
ORCHPHARMA.NS balance_sheet (annual, 2024-03-31) — Assets Held For Sale Current: 0.00
ORCHPHARMA.NS balance_sheet (annual, 2024-03-31) — Available For Sale Securities: 89137000.00
ORCHPHARMA.NS income_statement (annual, 2024-03-31) — Basic Average Shares: 48365183.00
ORCHPHARMA.NS income_statement (annual, 2024-03-31) — Basic EPS: 19.06
ORCHPHARMA.NS cash_flow (annual, 2024-03-31) — Beginning Cash Position: 225971000.00
ORCHPHARMA.NS balance_sheet (annual, 2024-03-31) — Buildings And Improvements: 1858786000.00
ORCHPHARMA.NS cash_flow (annual, 2024-03-31) — Capital Expenditure: -648148000.00
ORCHPHARMA.NS balance_sheet (annual, 2024-03-31) — Capital Lease Obligations: 7033000.00
ORCHPHARMA.NS balance_sheet (annual, 2024-03-31) — Capital Stock: 507191000.00
ORCHPHARMA.NS balance_sheet (annual, 2024-03-31) — Cash And Cash Equivalents: 36009000.00
ORCHPHARMA.NS balance_sheet (annual, 2024-03-31) — Cash Cash Equivalents And Short Term Investments: 45238000.00
ORCHPHARMA.NS balance_sheet (annual, 2024-03-31) — Cash Equivalents: 0.00
ORCHPHARMA.NS balance_sheet (annual, 2024-03-31) — Cash Financial: 36009000.00
ORCHPHARMA.NS cash_flow (annual, 2024-03-31) — Change In Inventory: -354881000.00
ORCHPHARMA.NS cash_flow (annual, 2024-03-31) — Change In Other Current Assets: -395840000.00
ORCHPHARMA.NS cash_flow (annual, 2024-03-31) — Change In Payable: 548513000.00
ORCHPHARMA.NS cash_flow (annual, 2024-03-31) — Change In Receivables: 196467000.00
ORCHPHARMA.NS cash_flow (annual, 2024-03-31) — Change In Working Capital: -78378000.00
ORCHPHARMA.NS cash_flow (annual, 2024-03-31) — Changes In Cash: -189962000.00
ORCHPHARMA.NS balance_sheet (annual, 2024-03-31) — Common Stock: 507191000.00
ORCHPHARMA.NS balance_sheet (annual, 2024-03-31) — Common Stock Equity: 11694661000.00
ORCHPHARMA.NS cash_flow (annual, 2024-03-31) — Common Stock Issuance: 3919421000.00
ORCHPHARMA.NS balance_sheet (annual, 2024-03-31) — Construction In Progress: 255232000.00
ORCHPHARMA.NS income_statement (annual, 2024-03-31) — Cost Of Revenue: 4983866000.00
ORCHPHARMA.NS balance_sheet (annual, 2024-03-31) — Current Assets: 7907501000.00
ORCHPHARMA.NS balance_sheet (annual, 2024-03-31) — Current Capital Lease Obligation: 3333000.00
ORCHPHARMA.NS balance_sheet (annual, 2024-03-31) — Current Debt: 140475000.00
ORCHPHARMA.NS balance_sheet (annual, 2024-03-31) — Current Debt And Capital Lease Obligation: 143808000.00
ORCHPHARMA.NS balance_sheet (annual, 2024-03-31) — Current Deferred Taxes Assets: 0.00
ORCHPHARMA.NS balance_sheet (annual, 2024-03-31) — Current Liabilities: 2599743000.00
ORCHPHARMA.NS balance_sheet (annual, 2024-03-31) — Current Provisions: 20847000.00
ORCHPHARMA.NS cash_flow (annual, 2024-03-31) — Depreciation: 332371000.00
ORCHPHARMA.NS cash_flow (annual, 2024-03-31) — Depreciation And Amortization: 332371000.00
ORCHPHARMA.NS income_statement (annual, 2024-03-31) — Depreciation And Amortization In Income Statement: 332371000.00
ORCHPHARMA.NS income_statement (annual, 2024-03-31) — Depreciation Income Statement: 321065000.00
ORCHPHARMA.NS income_statement (annual, 2024-03-31) — Diluted Average Shares: 48365183.00
ORCHPHARMA.NS income_statement (annual, 2024-03-31) — Diluted EPS: 19.06
ORCHPHARMA.NS income_statement (annual, 2024-03-31) — Diluted NI Availto Com Stockholders: 921665000.00
ORCHPHARMA.NS income_statement (annual, 2024-03-31) — EBIT: 1082997000.00
ORCHPHARMA.NS income_statement (annual, 2024-03-31) — EBITDA: 1415368000.00
ORCHPHARMA.NS cash_flow (annual, 2024-03-31) — End Cash Position: 36009000.00
ORCHPHARMA.NS cash_flow (annual, 2024-03-31) — Financing Cash Flow: 1670404000.00
ORCHPHARMA.NS balance_sheet (annual, 2024-03-31) — Finished Goods: 744250000.00
ORCHPHARMA.NS cash_flow (annual, 2024-03-31) — Free Cash Flow: 611772000.00
ORCHPHARMA.NS cash_flow (annual, 2024-03-31) — Gain Loss On Sale Of PPE: 1884000.00
ORCHPHARMA.NS income_statement (annual, 2024-03-31) — General And Administrative Expense: 84264000.00
ORCHPHARMA.NS balance_sheet (annual, 2024-03-31) — Goodwill And Other Intangible Assets: 149185000.00
ORCHPHARMA.NS balance_sheet (annual, 2024-03-31) — Gross Accounts Receivable: 2390262000.00
ORCHPHARMA.NS balance_sheet (annual, 2024-03-31) — Gross PPE: 13143179000.00
ORCHPHARMA.NS income_statement (annual, 2024-03-31) — Gross Profit: 3206797000.00
ORCHPHARMA.NS income_statement (annual, 2024-03-31) — Interest Expense: 163545000.00
ORCHPHARMA.NS income_statement (annual, 2024-03-31) — Interest Expense Non Operating: 163545000.00
ORCHPHARMA.NS income_statement (annual, 2024-03-31) — Interest Income: 163481000.00
ORCHPHARMA.NS income_statement (annual, 2024-03-31) — Interest Income Non Operating: 163481000.00
ORCHPHARMA.NS cash_flow (annual, 2024-03-31) — Interest Paid Cff: -48964000.00
ORCHPHARMA.NS cash_flow (annual, 2024-03-31) — Interest Received Cfi: 120017000.00
ORCHPHARMA.NS balance_sheet (annual, 2024-03-31) — Inventory: 1493605000.00
ORCHPHARMA.NS balance_sheet (annual, 2024-03-31) — Invested Capital: 13039434000.00
ORCHPHARMA.NS cash_flow (annual, 2024-03-31) — Investing Cash Flow: -3120286000.00
ORCHPHARMA.NS balance_sheet (annual, 2024-03-31) — Investmentin Financial Assets: 89137000.00
ORCHPHARMA.NS balance_sheet (annual, 2024-03-31) — Investmentsin Associatesat Cost: 369260000.00
ORCHPHARMA.NS cash_flow (annual, 2024-03-31) — Issuance Of Capital Stock: 3919421000.00
ORCHPHARMA.NS cash_flow (annual, 2024-03-31) — Issuance Of Debt: 0.00
ORCHPHARMA.NS balance_sheet (annual, 2024-03-31) — Land And Improvements: 256472000.00
ORCHPHARMA.NS balance_sheet (annual, 2024-03-31) — Long Term Capital Lease Obligation: 3700000.00
ORCHPHARMA.NS balance_sheet (annual, 2024-03-31) — Long Term Debt: 1204298000.00
ORCHPHARMA.NS balance_sheet (annual, 2024-03-31) — Long Term Debt And Capital Lease Obligation: 1207998000.00
ORCHPHARMA.NS cash_flow (annual, 2024-03-31) — Long Term Debt Issuance: 0.00
ORCHPHARMA.NS cash_flow (annual, 2024-03-31) — Long Term Debt Payments: -2085472000.00
ORCHPHARMA.NS balance_sheet (annual, 2024-03-31) — Long Term Equity Investment: 369260000.00
ORCHPHARMA.NS balance_sheet (annual, 2024-03-31) — Long Term Provisions: 36337000.00
ORCHPHARMA.NS balance_sheet (annual, 2024-03-31) — Machinery Furniture Equipment: 10609504000.00
ORCHPHARMA.NS cash_flow (annual, 2024-03-31) — Net Business Purchase And Sale: 0.00
ORCHPHARMA.NS cash_flow (annual, 2024-03-31) — Net Common Stock Issuance: 3919421000.00
ORCHPHARMA.NS balance_sheet (annual, 2024-03-31) — Net Debt: 1308764000.00
ORCHPHARMA.NS cash_flow (annual, 2024-03-31) — Net Foreign Currency Exchange Gain Loss: 76264000.00
ORCHPHARMA.NS income_statement (annual, 2024-03-31) — Net Income: 921665000.00
ORCHPHARMA.NS income_statement (annual, 2024-03-31) — Net Income Common Stockholders: 921665000.00
ORCHPHARMA.NS income_statement (annual, 2024-03-31) — Net Income Continuous Operations: 921665000.00
ORCHPHARMA.NS income_statement (annual, 2024-03-31) — Net Income Discontinuous Operations: 0.00
ORCHPHARMA.NS income_statement (annual, 2024-03-31) — Net Income From Continuing And Discontinued Operation: 921665000.00
ORCHPHARMA.NS income_statement (annual, 2024-03-31) — Net Income From Continuing Operation Net Minority Interest: 921665000.00
ORCHPHARMA.NS cash_flow (annual, 2024-03-31) — Net Income From Continuing Operations: 890474000.00
ORCHPHARMA.NS income_statement (annual, 2024-03-31) — Net Income Including Noncontrolling Interests: 921665000.00
ORCHPHARMA.NS income_statement (annual, 2024-03-31) — Net Interest Income: -3875000.00
ORCHPHARMA.NS cash_flow (annual, 2024-03-31) — Net Investment Purchase And Sale: -2592155000.00
ORCHPHARMA.NS cash_flow (annual, 2024-03-31) — Net Issuance Payments Of Debt: -2200053000.00
ORCHPHARMA.NS cash_flow (annual, 2024-03-31) — Net Long Term Debt Issuance: -2200053000.00
ORCHPHARMA.NS income_statement (annual, 2024-03-31) — Net Non Operating Interest Income Expense: -3875000.00
ORCHPHARMA.NS balance_sheet (annual, 2024-03-31) — Net PPE: 6451162000.00
ORCHPHARMA.NS cash_flow (annual, 2024-03-31) — Net PPE Purchase And Sale: -648148000.00
ORCHPHARMA.NS cash_flow (annual, 2024-03-31) — Net Short Term Debt Issuance: 0.00
ORCHPHARMA.NS balance_sheet (annual, 2024-03-31) — Net Tangible Assets: 11545476000.00
ORCHPHARMA.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Liabilities: 0.00
ORCHPHARMA.NS balance_sheet (annual, 2024-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 36337000.00
ORCHPHARMA.NS balance_sheet (annual, 2024-03-31) — Non Current Prepaid Assets: 572494000.00
ORCHPHARMA.NS income_statement (annual, 2024-03-31) — Normalized EBITDA: 1421879000.00
ORCHPHARMA.NS income_statement (annual, 2024-03-31) — Normalized Income: 926222700.00
ORCHPHARMA.NS cash_flow (annual, 2024-03-31) — Operating Cash Flow: 1259920000.00
ORCHPHARMA.NS income_statement (annual, 2024-03-31) — Operating Income: 784691000.00
ORCHPHARMA.NS income_statement (annual, 2024-03-31) — Operating Revenue: 8190663000.00
ORCHPHARMA.NS balance_sheet (annual, 2024-03-31) — Ordinary Shares Number: 50719105.00
ORCHPHARMA.NS balance_sheet (annual, 2024-03-31) — Other Current Assets: 1148656000.00
ORCHPHARMA.NS balance_sheet (annual, 2024-03-31) — Other Current Liabilities: 35906000.00
ORCHPHARMA.NS balance_sheet (annual, 2024-03-31) — Other Equity Interest: 685606000.00
ORCHPHARMA.NS balance_sheet (annual, 2024-03-31) — Other Intangible Assets: 149185000.00
ORCHPHARMA.NS balance_sheet (annual, 2024-03-31) — Other Inventories: 28959000.00
ORCHPHARMA.NS cash_flow (annual, 2024-03-31) — Other Non Cash Items: 64000.00
ORCHPHARMA.NS balance_sheet (annual, 2024-03-31) — Other Non Current Assets: 91303000.00
ORCHPHARMA.NS income_statement (annual, 2024-03-31) — Other Non Operating Income Expenses: 77801000.00
ORCHPHARMA.NS income_statement (annual, 2024-03-31) — Other Operating Expenses: 898497000.00
ORCHPHARMA.NS balance_sheet (annual, 2024-03-31) — Other Payable: 83947000.00
ORCHPHARMA.NS balance_sheet (annual, 2024-03-31) — Other Properties: 163185000.00
ORCHPHARMA.NS balance_sheet (annual, 2024-03-31) — Other Receivables: 48067000.00
ORCHPHARMA.NS balance_sheet (annual, 2024-03-31) — Other Short Term Investments: 9229000.00
ORCHPHARMA.NS income_statement (annual, 2024-03-31) — Other Special Charges: 1884000.00
ORCHPHARMA.NS income_statement (annual, 2024-03-31) — Otherunder Preferred Stock Dividend: 0.00
ORCHPHARMA.NS balance_sheet (annual, 2024-03-31) — Payables: 2379716000.00
ORCHPHARMA.NS balance_sheet (annual, 2024-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 20847000.00
ORCHPHARMA.NS balance_sheet (annual, 2024-03-31) — Prepaid Assets: 596051000.00
ORCHPHARMA.NS income_statement (annual, 2024-03-31) — Pretax Income: 919452000.00
ORCHPHARMA.NS balance_sheet (annual, 2024-03-31) — Properties: 0.00
ORCHPHARMA.NS cash_flow (annual, 2024-03-31) — Provisionand Write Offof Assets: -2651000.00
ORCHPHARMA.NS cash_flow (annual, 2024-03-31) — Purchase Of Business: 0.00
ORCHPHARMA.NS cash_flow (annual, 2024-03-31) — Purchase Of PPE: -648148000.00
ORCHPHARMA.NS balance_sheet (annual, 2024-03-31) — Raw Materials: 720396000.00
ORCHPHARMA.NS income_statement (annual, 2024-03-31) — Reconciled Cost Of Revenue: 4983866000.00
ORCHPHARMA.NS income_statement (annual, 2024-03-31) — Reconciled Depreciation: 332371000.00
ORCHPHARMA.NS income_statement (annual, 2024-03-31) — Rent And Landing Fees: 33417000.00
ORCHPHARMA.NS income_statement (annual, 2024-03-31) — Rent Expense Supplemental: 33417000.00
ORCHPHARMA.NS cash_flow (annual, 2024-03-31) — Repayment Of Debt: -2085472000.00
ORCHPHARMA.NS income_statement (annual, 2024-03-31) — Research And Development: 70937000.00
ORCHPHARMA.NS balance_sheet (annual, 2024-03-31) — Restricted Cash: 2620413000.00
ORCHPHARMA.NS balance_sheet (annual, 2024-03-31) — Retained Earnings: -21765246000.00
ORCHPHARMA.NS cash_flow (annual, 2024-03-31) — Sale Of PPE: 0.00
ORCHPHARMA.NS income_statement (annual, 2024-03-31) — Selling And Marketing Expense: 238563000.00
ORCHPHARMA.NS income_statement (annual, 2024-03-31) — Selling General And Administration: 322827000.00
ORCHPHARMA.NS balance_sheet (annual, 2024-03-31) — Share Issued: 50719105.00
ORCHPHARMA.NS income_statement (annual, 2024-03-31) — Special Income Charges: -6511000.00
ORCHPHARMA.NS balance_sheet (annual, 2024-03-31) — Stockholders Equity: 11694661000.00
ORCHPHARMA.NS balance_sheet (annual, 2024-03-31) — Tangible Book Value: 11545476000.00
ORCHPHARMA.NS income_statement (annual, 2024-03-31) — Tax Effect Of Unusual Items: -1953300.00
ORCHPHARMA.NS income_statement (annual, 2024-03-31) — Tax Provision: -31191000.00
ORCHPHARMA.NS income_statement (annual, 2024-03-31) — Tax Rate For Calcs: 0.30
ORCHPHARMA.NS balance_sheet (annual, 2024-03-31) — Taxes Receivable: 16432000.00
ORCHPHARMA.NS cash_flow (annual, 2024-03-31) — Taxes Refund Paid: 6287000.00
ORCHPHARMA.NS balance_sheet (annual, 2024-03-31) — Total Assets: 15538739000.00
ORCHPHARMA.NS balance_sheet (annual, 2024-03-31) — Total Capitalization: 12898959000.00
ORCHPHARMA.NS balance_sheet (annual, 2024-03-31) — Total Debt: 1351806000.00
ORCHPHARMA.NS balance_sheet (annual, 2024-03-31) — Total Equity Gross Minority Interest: 11694661000.00
ORCHPHARMA.NS income_statement (annual, 2024-03-31) — Total Expenses: 7405972000.00
ORCHPHARMA.NS balance_sheet (annual, 2024-03-31) — Total Liabilities Net Minority Interest: 3844078000.00
ORCHPHARMA.NS balance_sheet (annual, 2024-03-31) — Total Non Current Assets: 7631238000.00
ORCHPHARMA.NS balance_sheet (annual, 2024-03-31) — Total Non Current Liabilities Net Minority Interest: 1244335000.00
ORCHPHARMA.NS income_statement (annual, 2024-03-31) — Total Other Finance Cost: 3811000.00
ORCHPHARMA.NS income_statement (annual, 2024-03-31) — Total Unusual Items: -6511000.00
ORCHPHARMA.NS income_statement (annual, 2024-03-31) — Total Unusual Items Excluding Goodwill: -6511000.00
ORCHPHARMA.NS balance_sheet (annual, 2024-03-31) — Work In Process: 1148656000.00
ORCHPHARMA.NS balance_sheet (annual, 2024-03-31) — Working Capital: 5307758000.00
ORCHPHARMA.NS income_statement (annual, 2024-03-31) — Write Off: 4627000.00
ORCHPHARMA.NS balance_sheet (quarterly, 2024-09-30) — Accounts Payable: 2238247000.00
ORCHPHARMA.NS balance_sheet (quarterly, 2024-09-30) — Accounts Receivable: 2151993000.00
ORCHPHARMA.NS balance_sheet (quarterly, 2024-09-30) — Available For Sale Securities: 525056000.00
ORCHPHARMA.NS balance_sheet (quarterly, 2024-09-30) — Capital Lease Obligations: 5367000.00
ORCHPHARMA.NS balance_sheet (quarterly, 2024-09-30) — Capital Stock: 507191000.00
ORCHPHARMA.NS balance_sheet (quarterly, 2024-09-30) — Cash And Cash Equivalents: 43531000.00
ORCHPHARMA.NS balance_sheet (quarterly, 2024-09-30) — Cash Cash Equivalents And Short Term Investments: 2479426000.00
ORCHPHARMA.NS balance_sheet (quarterly, 2024-09-30) — Common Stock: 507191000.00
ORCHPHARMA.NS balance_sheet (quarterly, 2024-09-30) — Common Stock Equity: 12242432000.00
ORCHPHARMA.NS balance_sheet (quarterly, 2024-09-30) — Construction In Progress: 250204000.00
ORCHPHARMA.NS balance_sheet (quarterly, 2024-09-30) — Current Assets: 8333657000.00
ORCHPHARMA.NS balance_sheet (quarterly, 2024-09-30) — Current Capital Lease Obligation: 3333000.00
ORCHPHARMA.NS balance_sheet (quarterly, 2024-09-30) — Current Debt: 384631000.00
ORCHPHARMA.NS balance_sheet (quarterly, 2024-09-30) — Current Debt And Capital Lease Obligation: 387964000.00
ORCHPHARMA.NS balance_sheet (quarterly, 2024-09-30) — Current Liabilities: 2811013000.00
ORCHPHARMA.NS balance_sheet (quarterly, 2024-09-30) — Current Provisions: 13734000.00
ORCHPHARMA.NS balance_sheet (quarterly, 2024-09-30) — Goodwill And Other Intangible Assets: 185944000.00
ORCHPHARMA.NS balance_sheet (quarterly, 2024-09-30) — Gross PPE: 6561482000.00
ORCHPHARMA.NS balance_sheet (quarterly, 2024-09-30) — Inventory: 3205788000.00
ORCHPHARMA.NS balance_sheet (quarterly, 2024-09-30) — Invested Capital: 13886444000.00
ORCHPHARMA.NS balance_sheet (quarterly, 2024-09-30) — Investmentin Financial Assets: 525056000.00
ORCHPHARMA.NS balance_sheet (quarterly, 2024-09-30) — Long Term Capital Lease Obligation: 2034000.00
ORCHPHARMA.NS balance_sheet (quarterly, 2024-09-30) — Long Term Debt: 1259381000.00
ORCHPHARMA.NS balance_sheet (quarterly, 2024-09-30) — Long Term Debt And Capital Lease Obligation: 1261415000.00
ORCHPHARMA.NS balance_sheet (quarterly, 2024-09-30) — Long Term Provisions: 36581000.00
ORCHPHARMA.NS balance_sheet (quarterly, 2024-09-30) — Net Debt: 1600481000.00
ORCHPHARMA.NS income_statement (quarterly, 2024-09-30) — Net Income Extraordinary: 13361000.00